We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Increasing Muscle Mass May Aid Diabetics

By Biotechdaily staff writers
Posted on 21 May 2002
A study has shown that mice genetically altered to promote obesity but lacking the gene that codes for myostatin stay leaner and healthier and do not develop resistance to insulin. More...
Myostatin is a protein known to limit muscle growth. Conducted by researchers at the Johns Hopkins School of Medicine (Baltimore,MD, USA), the study was reported in the March 1, 2002, issue of the Journal of Clinical Investigation.

Previous studies have shown that mice without myostatin become muscle-bound "mighty mice.” Now the researchers show that mice without this protein, even mice that usually become obese, gain much less fat as they age. Regular and obese mice without myostatin gained less fat, as they got older, even though they ate about the same amounts of food as other mice. In fact, "mighty mice” outweighed their counterparts when young, but by 10 months of age weighed the same or less than other mice, which had bulked up with fat.

In people with type 2 diabetes, tissues--especially muscle--stop responding to insulin and therefore do not soak up sugar from the blood. Most current treatment strategies for diabetes target the insulin pathway. The new research suggests that an alternative approach might be to increase muscle mass, which may make the body more efficient at taking up sugar from the blood. The investigators caution that the team is studying genetic knockouts and does not yet know whether it will be possible to block myostatin in adult animals and see similar effects. In any case, myostatin-blocking agents still need to be developed.

"Some normal mice put on a lot of fat as they age and others not as much, but animals lacking myostatin do not put on much fat at all,” says Se Jin Lee, M.D., Ph.D., professor of molecular biology and genetics at Hopkins' Institute for Basic Biomedical Sciences. "This tells me that myostatin might be a useful target for preventing or treating obesity and associated conditions, like diabetes.”




Related Links:
Johns Hopkins

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.